Back to User profile » Dr Lin Shao
Papers published by Dr Lin Shao:
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report
Zhao Y, Chen Y, Huang H, Li X, Shao L, Ding H
OncoTargets and Therapy 2021, 14:3063-3067
Published Date: 7 May 2021
Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report
Zhou R, Song L, Zhang W, Shao L, Li X, Li X
OncoTargets and Therapy 2021, 14:2847-2851
Published Date: 28 April 2021
Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report
Jiao Y, Fang C, Yang Y, Shao L, Huang Y, Sun Q, Dong Y
OncoTargets and Therapy 2021, 14:2417-2421
Published Date: 7 April 2021
An EGFR-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report
Chen Q, Huang Y, Shao L, Han-Zhang H, Yang F, Wang Y, Liu J, Gan J
OncoTargets and Therapy 2020, 13:1845-1849
Published Date: 28 February 2020